Admedus Profile

0.07
USD 0.015  30.00%

Admedus Summary

Admedus Limited (AMEUF) is traded on OTC Market in USA. It is located in 301 Coronation Drive and employs 12 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 15.03M. Admedus Limited classifies itself under Healthcare sector and is part of Biotechnology industry. This company has 284M outstanding shares. ADMEDUS has accumulated about 3.27M in cash with (7.18M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Admedus Probability Of Bankruptcy

Admedus Target Price Odds Analysis

Odds Below 0.065HorizonTargetOdds Above 0.065
11.08%30 days 0.07 88.89%
Based on normal probability distribution, the odds of Admedus to move above current price in 30 days from now is about 88.89% (This Admedus Limited probability density function shows the probability of Admedus Stock to fall within a particular range of prices over 30 days) .

Admedus Limited Risk Profiles

Admedus Key Fundamentals

Admedus Against Markets

Admedus Current Ratings

Admedus Limited 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
6
Chance of
Financial Distress (0 to 100%)
57%
Equity ratings for Admedus Limited are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Admedus Limited, a healthcare company, develops, commercializes, and distributes next generation medical technologies and devices. The company was formerly known as Allied Healthcare Group Limited and changed its name to Admedus Limited in November 2013. Admedus operates under Biotechnology classification in USA and is traded on OTC Market. more
NameAdmedus Limited
CEOLee RodneView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address301 Coronation Drive
ExchangeOTC Market
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.admedus.com
Phone61 8 9266 0100
CurrencyUSD - US Dollar
Next Fiscal Year EndJune 30, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndJune 30, 2017

Admedus Directors

Admedus Corporate Directors

William Rowley Non-Executive Director
Mathew Ratty Non-Executive Director
John Seaberg Non-Executive Independent Director
Check also Trending Equities. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Search macroaxis.com